Skip to main content
. 2018 Oct 30;84(22):e01701-18. doi: 10.1128/AEM.01701-18

TABLE 4.

Cosynthesis assays in liquid SA mediuma

Cosynthesis assaya Strain (gene mutated)b
Clavulanic acid bioassay resultc
Donor Receptor
1 S. clavuligerus ΔoppA2::acc (oppA2) S. clavuligerus pyc::aph (ceaS) ++++
2 S. clavuligerus ΔoppA2::acc (oppA2) S. clavuligerus RFL35 (bls2) ++++
3 S. clavuligerus ΔoppA2::acc (oppA2) S. clavuligerus orf14::aph −−−−−
4 S. clavuligerus ΔoppA2::acc (oppA2) S. clavuligerus cyp::aph (cyp) −−−−−
5 S. clavuligerus ΔoppA2::acc (oppA2) S. clavuligerus oppA1::aph (oppA1) −−−−−
6 S. clavuligerus cyp::aph (cyp) S. clavuligerus pyc::aph (ceaS) −−−−−
7 S. clavuligerus cyp::aph (cyp) S. clavuligerus RFL35 (bls2) −−−−−
8 S. clavuligerus pyc::aph (ceaS) S. clavuligerus ΔoppA2::acc (oppA2) −−−−−
9 S. clavuligerus RFL35 (bls2) S. clavuligerus ΔoppA2::acc (oppA2) −−−−−
a

Assays 1 to 5 were also carried out using mixed cultures of both strains. The complementation results in the bioassay were identical.

b

Donor strains were from spent sterile supernatants; receptor strains were from growing cultures.

c

++++, positive cosynthesis; −−−−−, negative cosynthesis. CA bioassays of each separated strain were always negative. None of the strains shown in this table produces clavulanic acid by itself. All the strains produced cephamycin C.